Comparative cardiovascular safety of insulin secretagogues following hospitalization for ischemic heart disease among type 2 diabetes patients: a cohort study. [electronic resource]
Producer: 20151110Description: 196-202 p. digitalISSN:- 1873-460X
- Aged
- Aged, 80 and over
- Alberta -- epidemiology
- Blue Cross Blue Shield Insurance Plans
- Carbamates -- adverse effects
- Cardiovascular Diseases -- chemically induced
- Cohort Studies
- Databases, Factual
- Diabetes Mellitus, Type 2 -- complications
- Diabetic Angiopathies -- chemically induced
- Diabetic Cardiomyopathies -- chemically induced
- Female
- Gliclazide -- adverse effects
- Glyburide -- adverse effects
- Hospitalization
- Humans
- Hypoglycemic Agents -- adverse effects
- Male
- Myocardial Ischemia -- complications
- Piperidines -- adverse effects
- Proportional Hazards Models
- Retrospective Studies
- Risk
- Universal Health Insurance
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.